Harvard Bioscience (HBIO) Interest Coverage Ratio (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Interest Coverage Ratio of 0.82 for Q1 2026, up 98.45% year-over-year from 0.41 in Q1 2025, and up 40.03% quarter-over-quarter from 1.37 in Q4 2025.
Harvard Bioscience (HBIO) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Interest Coverage Ratio for 17 consecutive years, with 0.82 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 98.45% year-over-year to 0.82; the TTM figure through Mar 2026 stood at 0.06 (up 99.89% YoY), while the FY2025 annual figure was 2.44, down 599.35% from the prior year.
- Interest Coverage Ratio grew to 0.82 in Q1 2026 per HBIO's latest filing, from 1.37 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 1.69 in Q2 2022 and bottomed at 52.89 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 3.51 across 5 years, with a median of 0.46 in 2025.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 12401.05% — and 2025, when it plunged 6236.04%.
- Harvard Bioscience's Interest Coverage Ratio stood at 0.34 in 2022, then gained by 5.66% to 0.36 in 2023, then tumbled by 93.76% to 0.02 in 2024, then plunged by 6236.04% to 1.37 in 2025, then surged by 40.03% to 0.82 in 2026.
- Business Quant data shows HBIO's Interest Coverage Ratio at 0.82 in Q1 2026, 1.37 in Q4 2025, and 0.21 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 5.02 |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.21 |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | - |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 68.88 |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -1.48 |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -1.37 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -52.89 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | -1.27 |
| Jun 30, 2024 | -1.17 |
| Mar 31, 2024 | -2.09 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 1.30 |
| Dec 31, 2022 | 0.34 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | 1.69 |
| Mar 31, 2022 | -2.83 |
| Dec 31, 2021 | -2.15 |
| Sep 30, 2021 | 0.04 |